Gary Koe
Vermögen: 1 $ am 31.08.2026
Vermögen: 1 $ am 31.08.2026
Dr. Gary S.
Koe is a Chief Technical Officer at Electra Therapeutics, Inc. Dr. Koe was previously employed as a Vice President-Technical Operations by Star Therapeutics, Inc. and an Executive Director by Aravive, Inc. He received his undergraduate degree from the University of California, Davis and a doctorate degree from the University of California, Los Angeles.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.09.2026 | 63 656 ( 0,16 % ) | 1 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ELECTRA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2023 |
| ARAVIVE, INC. | Direktor/Vorstandsmitglied | 01.01.2019 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aravive, Inc.
Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
Electra Therapeutics, Inc.
Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological and cancer diseases | Health Technology |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen